Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Charles Wiley Killed in Crash on Camino Del Norte


Man Hit by Car in Fatal Lake Elsinore Accident 

Lake Elsinore, CA (March 2, 2020) – A man was killed in a pedestrian crash in Lake Elsinore. The fatal accident occurred on the morning of March 2 on Camino Del Norte.

Charles Wiley, 27, was crossing the street at the 18800 block of Camino Del Norte when he was hit by a car. Wiley died in the crash. The driver remained at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of Charles Wiley.

#Lake Elsinore

#92532


December 20, 2019

Christopher Vellios Killed in Crash at Highway 111 and Frank Sinatra Road

Victim Run Over by Vehicle in Fatal Rancho Mirage Accident...


October 22, 2019

Ramon Zaragoza Injured in Crash at Highway 29 and Highway 221

Driver Runs Red Light in Napa Accident Napa, CA (October 20, 2019) – One pers...


January 2, 2020

2 Deputies Injured in Crash on Highway 12 at Melita Road

Police Vehicle Hits Guardrail in Santa Rosa Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.